Stock detail
NeoGenomics (NEO) stock price, chart, and key data
View NeoGenomics stock price, chart movement, and headline metrics on Woodstock's stock detail page.

Stock detail
NeoGenomics
NEO · XNAS
$17.37
-1.19%
-$0.21
Key metrics
52-week range
$2.75 - $0.00
Close price
$17.58
Market cap
$2.3B
P/E ratio
-43.95
Beta
0.65
About the company
NeoGenomics Inc
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics. Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas.
Analyst rating summary
A current read on analyst sentiment from the insight feed.
Mean target
$18.33
5
Buy
/ 8
Recent calls
08/27/2026
Piper Sandler
David Westenberg
Buy · Price target $21.00
08/27/2026
William Blair
Matt Larew
Hold
07/29/2026
Craig-Hallum
Matt Hewitt
Buy · Price target $19.00
Ticker holders
Review politician disclosures and insider transactions in tabs.
Holder directory
Select a heading to reorder by name, activity date, buy/sell, or displayed value.
#1Deborah k. Ross democrat · House · NC-2 spouse |
| $45,003/$97,502/$150,000 |
#2Dwight Evans democrat · House · PA-3 self |
| $4,004/$32,002/$60,000 |
#3Donald J Trump republican · Executive self |
| 1,002/2,171/3,340 |
#4Gilbert Cisneros democrat · House · CA-31 self |
| 125/1,000/1,875 |
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app